Drugs / FCRx
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00497926 | Mar 2008 → Mar 2023 | kidney failure | Talaris Therapeutics Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FCRx | “We previously showed full donor chimerism and immunosuppression withdrawal in highly mismatched allograft recipients using a bioengineered stem cell product (FCRx).” PMID 29191961 ↗ Nov 2017 |
| Modality | Cell therapy | “FCRx cell therapy” NCT00497926 ↗ |